A look at the U.S. markets ahead of the open, with CNBC's Kelly Evans, including a deal in the drug sector with Canada's Valeant Pharmaceutical buying Medicis for $2.6 billion in cash.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT